Article
EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity.
Cancer research - 15 May 2007
Vikis Haris, Sato Mitsuo, James Michael, Wang Daolong, Wang Yian, Wang Min, Jia Dongmei, Liu Yan, Bailey-Wilson Joan E, Amos Christopher I, Pinney Susan M, Petersen Gloria M, de Andrade Mariza, Yang Ping, Wiest Jonathan S, Fain Pamela R, Schwartz Ann G, Gazdar Adi, Gaba Colette, Rothschild Henry, Mandal Diptasri, Kupert Elena, Seminara Daniela, Viswanathan Avinash, Govindan Ramaswamy, Minna John, Anderson Marshall W, You Ming
Abstract excerpt
The use of tyrosine kinase inhibitors (TKI) has yielded great success in treatment of lung adenocarcinomas. However, patients who develop resistance to TKI treatment often acquire a somatic resistance mutation (T790M) located in the catalytic cleft of the epidermal growth factor receptor (EGFR) e...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
